Drug repurposing in cancer therapy: approaches and applications (Record no. 58644)

MARC details
000 -LEADER
fixed length control field 02041cam a2200217 4500
001 - CONTROL NUMBER
control field 9780128199039
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220107t2020 xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128199039
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128196687
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name To, Kenneth K.W.
245 #0 - TITLE STATEMENT
Title Drug repurposing in cancer therapy: approaches and applications
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. London :
Name of publisher, distributor, etc. Academic Press,
Date of publication, distribution, etc. 2020
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xi, 437 pages):illustrations (chiefly color)
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Drug repurposing for cancer therapy--an introduction -- A ligand-centric approach to identify potential drugs for repurposing: case study with aurora kinase inhibitors -- Machine learning strategies for identifying repurposed drugs for cancer therapy -- Unveiling potential anticancer drugs through in silico drug repurposing approaches -- Increasing opportunities of drug repurposing for treating breast cancer by the integration of molecular, histological, and systemic approaches -- The success story of drug repurposing in breast cancer -- A personalized medicine approach to drug repurposing for the treatment of breast cancer molecular subtypes -- Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma -- Stories of drug repurposing for pancreatic cancer treatment--Past, present, and future -- Animal models and in vivo investigations for drug repurposing in lung cancer -- Identification of chemosensitizers by drug repurposing to enhance the efficacy of cancer therapy -- Drugs repurposed to potentiate immunotherapy for cancer treatment -- Nanoparticle-based formulation for drug repurposing in cancer treatment -- Nanotechnological approaches in cancer: the role of celecoxib and disulfiram -- Clinical trials on combination of repurposed drugs and anticancer therapies."
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element Cancer
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element Off-label drug use.
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Cho, William C.S.
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20190001161">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20190001161</a>
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Newham Library (Barts Health) Newham Library (Barts Health) Online 03/10/2023   03/10/2023 03/10/2023 Electronic book
        Royal London Library (Barts Health) Royal London Library (Barts Health) Online 03/10/2023   03/10/2023 03/10/2023 Electronic book
        St Bartholomew's Library (Barts Health) St Bartholomew's Library (Barts Health) Online 20/04/2022   20/04/2022 20/04/2022 Electronic book
        Whipps Cross Library (Barts Health) Whipps Cross Library (Barts Health) Online 03/10/2023   03/10/2023 03/10/2023 Electronic book
London Health Libraries Koha Consortium privacy notice